Heart failure & cardiomyopathiesGuideline or statement
Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC
- Scientific statement
Recommendations
As issued by the authors
European HASs differ significantly in which patients are prioritized and how prioritization is performed
1-year survival after heart transplantation is a poor metric of HAS performance
HAS impact should be evaluated by several measures (survival from listing, time to transplantation, characteristics of transplanted patients) and over a longer time interval to understand the balance of early and late post-transplant risks and benefit
Original publication
Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC. Eur J Heart Fail. Published 7 May 2025. doi:10.1002/ejhf.3681
Summarised from the published abstract; every number is checked against it